Arcutis Biotherapeutics Inc (ARQT) — Capital Reinvestment Ratio

Latest as of June 2025: 0.24x

Arcutis Biotherapeutics Inc (ARQT) has a Capital Reinvestment Ratio of 0.24x as of June 2025, meaning it reinvests 0% of its operating cash flow ($324.00K) in capital expenditures ($78.00K). See debt-free asset ratio of Arcutis Biotherapeutics Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.24x

Capex / Operating Cash Flow

Operating Cash Flow

$324.00K

USD

Capital Expenditures

$78.00K

USD

Data as of

Jun 2025

Most recent filing

Annual Capital Reinvestment Ratio for Arcutis Biotherapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Arcutis Biotherapeutics Inc from None to None. For live market cap and broader valuation context, see Arcutis Biotherapeutics Inc (ARQT) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow